Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $93.06 +0.82%
Revenue Growth %: +11.0%
Financial Fact:
Earnings before income taxes: 1.19B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Revenue Growth %: +11.0%
Financial Fact:
Earnings before income taxes: 1.19B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
